| pubmed-article:15030987 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0524910 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0035020 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:15030987 | lifeskim:mentions | umls-concept:C0301630 | lld:lifeskim |
| pubmed-article:15030987 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15030987 | pubmed:dateCreated | 2004-3-19 | lld:pubmed |
| pubmed-article:15030987 | pubmed:abstractText | Treatment of chronic hepatitis C with interferon can be ineffective due to relapse. We aimed to reduce the 40% relapse rate of 6 months interferon-ribavirin combination therapy by prolonging treatment to 18 months. | lld:pubmed |
| pubmed-article:15030987 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15030987 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15030987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15030987 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15030987 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:15030987 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:NevensFrederi... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:LefebvreVéron... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:HansenBettina... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:SchalmSolko... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:DelwaideJeanJ | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:BourgeoisNadi... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:WeeginkChrist... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:HenrionJeanJ | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:BrouwerJohann... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:BekkeringFran... | lld:pubmed |
| pubmed-article:15030987 | pubmed:author | pubmed-author:Benelux... | lld:pubmed |
| pubmed-article:15030987 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15030987 | pubmed:volume | 40 | lld:pubmed |
| pubmed-article:15030987 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15030987 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15030987 | pubmed:pagination | 689-95 | lld:pubmed |
| pubmed-article:15030987 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:meshHeading | pubmed-meshheading:15030987... | lld:pubmed |
| pubmed-article:15030987 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15030987 | pubmed:articleTitle | Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients. | lld:pubmed |
| pubmed-article:15030987 | pubmed:affiliation | Department of Hepatogastroenterology, Erasmus Medical Center, Rotterdam, The Netherlands. | lld:pubmed |
| pubmed-article:15030987 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15030987 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15030987 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:15030987 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15030987 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15030987 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15030987 | lld:pubmed |
